Hematological toxicity and nandrolone decanoate during polychemotherapy of bronchogenic carcinoma. Preliminary note

de Sanctis, C.; De Luca, S.; Succi, A.; Gargiulo, P.; Mugnaini, L.; Antilli, A.; Signora, M.; Cruciani, A.R.

La Clinica Terapeutica 118(3): 183-186

1986


ISSN/ISBN: 0009-9074
PMID: 3757462
Document Number: 269842
The results are reported of a pilot study intended to assess the possible protective action of the androgenic agent nandrolone decanoate during cytostatic treatment of bronchogenic carcinoma.

Document emailed within 1 workday
Secure & encrypted payments